Figure 1: Disparity in SNP and microsatellite diversity between P. vivax and P. falciparum. Figure 2: Neighbor-joining phylograms of P. vivax and P. falciparum constructed from presumably neutral SNPs ...

CLEVELAND - In a paradigm changing discovery, Plasmodium vivax (P. vivax)malaria has been identified in a population historically thought to be resistant to the disease, those who do not express the ...

Malaria is a significant public health threat, causing about 241 million cases worldwide in 2020. Although Plasmodium falciparum is reported to be the most common malaria parasite in Africa, P. vivax ...

Credit: Shutterstock. The approval was based on data from 3 randomized, double-blind studies, DETECTIVE Part 1 and Part 2 and GATHER. Krintafel is not indicated for the treatment of acute P. vivax ...

Researchers have discovered recent genetic mutations in a parasite that causes over 100 million cases of malaria annually -- changes that may render tens of millions of Africans who had been ...

A particular strain of malaria parasite, which was believed to be less fatal, is now causing high disease burden, latest assessment by the World Health Organization shows. NEW DELHI: A particular ...

Immune modulation of Plasmodium vivax and P. falciparum gametocytes occurs over the course of erythrocytic infection. The response is linked to proliferative and inflammatory responses, which may be ...

GlaxoSmithKline is close to ending a six-decade drought in relapse-preventing therapies for Plasmodium vivax—one of the most common forms of malaria—after its new drug tafenoquine cleared an FDA ...

On 18 December 2024, the World Health Organization (WHO) prequalified the first diagnostic test for glucose-6-phosphate dehydrogenase (G6PD) deficiency which can help to safely deliver WHO-recommended ...

In a paradigm changing discovery, Plasmodium vivax (P. vivax) malaria has been identified in a population historically thought to be resistant to the disease, those who do not express the Duffy blood ...